Nicoya Partners with INOVIQ To Develop a SubB2M-Based Test for Cancer Risk Assessment
Oct 13, 2022
Nicoya Lifesciences Expands Into Molecular Testing With Acquisition of LSK Technologies
May 2, 2022
Nicoya Acquires LSK Technologies, Expanding Digital Platform into Molecular Testing
May 2, 2022
Nicoya Lifesciences to Further Develop Alto SPR Platform, Enter International Markets
December 21, 2021
Nicoya Extends Series A Financing With Additional $20m to Meet Demand of Rapidly Growing Proteomics Industry
December 16, 2021
Nicoya Lifesciences to receive up to $2 million in response to the Point of Care and Home Diagnostic Kit for COVID-19 challenge
May 26, 2021
Rapid detection of COVID-19 and its variants: Nicoya develops innovative saliva test kit
May 7, 2021
Nicoya promised additional funding from federal government to develop COVID-19 test
Apr 14, 2021
Nicoya Lifesciences receives additional funding for next-phase development of its rapid, saliva-based COVID-19 diagnostic test
Apr 06, 2021
Nicoya receives over $1.9M in funding to continue the development of a portable, saliva-based COVID-19 test
Mar 29, 2021
Nicoya receives over $290K in funding to develop a portable COVID-19 diagnostic test
June 15, 2020
Nicoya Provides Complimentary Surface Plasmon Resonance Support for Researchers During COVID-19
April 30, 2020
Nicoya Launches Alto, the World’s First Digital Benchtop SPR System, to Accelerate Drug Discovery
January 23, 2020
Nicoya Raises $10 Million in Series A Funding to Make Drug Discovery Digital
January 14, 2020
FedDev Ontario announces a contribution of $2.57 million for Nicoya’s scale-up operations
May 3, 2019
Nicoya Lifesciences raises $2 million to change how the next generation of drugs will be discovered
January 31, 2018
Science startups make research faster, cheaper, more accurate – Globe and Mail
October 6, 2016
Nicoya Hires Senior Sales and Marketing Executive Jim Harp to Drive Global Expansion
April 4, 2016
